Buy these ASX growth shares this week: experts

Lithium, technology, and sleep treatment shares are where analysts are telling growth investors to put their money…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors looking for ASX growth shares to buy might want to look at the three listed below.

These shares have been named as buys and tipped to climb meaningfully from current levels. Here's what you need to know:

Broker looking at the share price on her laptop with green and red points in the background.

Image source: Getty Images

Pilbara Minerals Ltd (ASX: PLS)

This first ASX growth share to buy could be Pilbara Minerals. It is one of the world's leading lithium miners with a collection of high quality assets that are generating significant free cash flow. So much so, the company recently declared its maiden dividend. And while recent pressure on lithium prices has weighed on sentiment, the team at Morgans believe prices could soon benefit from "demand in the Chinese market [increasing] from March onwards."

Morgans currently has an add rating and $4.70 price target on this lithium miner's shares.

Readytech Holdings Ltd (ASX: RDY)

Another ASX growth share to buy could be Readytech. It is a leading provider of mission-critical software-as-a-service (SaaS) solutions for the education, employment services, workforce management, government and justice sectors. Goldman Sachs is bullish on the company due to its attractive valuation and exposure to government software. It notes that the latter "has been a pocket of strength and resilience" and expects it to help "deliver mid-teens organic growth at an expanding profit margin through the cycle."

Goldman has a buy rating and $4.40 price target on its shares.

ResMed Inc. (ASX: RMD)

A final ASX growth share to buy could be ResMed. It is a medical device company with a focus on the sleep disorder treatment market. Goldman is also bullish on ResMed and believes it is well-placed for growth in the coming years. In fact, its analysts "currently model an EPS CAGR of +11% (FY23-26E), with potential upside depending on how competitive/regulatory dynamics develop."

Goldman has a buy rating and $38.00 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ReadyTech and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended ReadyTech. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A woman shrugs and pulls awkward expression with her face.
Growth Shares

WiseTech shares just crashed. Can investors look past the company's governance issues?

WiseTech shares fell sharply after reports the AFP is investigating founder Richard White. Here is what investors need to know…

Read more »

A man and woman jump in the air and high five with both hands on a road after running.
Growth Shares

2 ASX growth shares that could double your money

Analysts believe these shares could soar up to 175% from here.

Read more »

A young bank customer wearing a yellow jumper smiles as she checks her bank balance on her phone.
Growth Shares

Where I'd invest $10,000 in ASX 200 shares in FY27

These three ASX 200 shares have different growth engines and all could reward patient investors over time.

Read more »

Young businesswoman sitting in kitchen and working on laptop.
Growth Shares

Down 80%, could this ASX growth share be dirt cheap?

The market has fallen out of love with this ASX growth share, but I think the longer-term opportunity remains attractive.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Growth Shares

3 ASX growth shares to buy next month

Why these stocks could outperform next.

Read more »

One girl leapfrogs over her friend's back.
Growth Shares

2 ASX growth shares experts think could double over 12 months

Analysts see triple-digit upside for these beaten-down stocks.

Read more »

Happy man at an ATM.
Growth Shares

Forget CBA: 3 ASX shares with better growth prospects

These shares might be better options for growth investors than Australia's largest bank.

Read more »

Three business people stand on platforms in the desert and look out through telescopes.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These ASX shares have excellent growth outlooks.

Read more »